Trial Profile
Safety and efficacy of fixed dose combination of Indapamide SR / Amlodipine in single-pill versus free dual therapy at the same dose over 12-week of treatment, with conditional titration based on the blood pressure control, in patients with mild to moderate uncontrolled essential hypertension: an international, multicentre, randomised, open-label study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Indapamide/amlodipine (Primary) ; Amlodipine; Indapamide
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors IRIS
- 11 Jun 2018 Results assessing office systolic blood pressure presented at the 28th European Meeting on Hypertension and Cardiovascular Protection
- 30 May 2014 New trial record